Cerilliant Introduces New Multi-Component Reference Solutions for Drug Interference Testing

ST. LOUIS -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first-ever reference solutions for qualitative evaluation of drug interferences in a testing laboratory's analytical methods. These seven multi-component solution mixes contain more than 50 of the most routinely monitored over-the-counter (OTC) [...]

New Transient CHO Expression System Provides Greater Confidence in Biologics Candidate Selection

CARLSBAD, Calif. -- Biopharmaceutical companies developing protein-based therapeutics now have access t o a new t ransient CHO expression syst em designed t o great ly enhance early phase drug screening. The Gibco ExpiCHO Expression System is a fully redesigned transient expression system that enables biologics developers to produce proteins in CHO cells from discovery [...]

SYGNIS Announces Global Launch of SunScript™ One Step Reverse Transcriptase-PCR Kit

Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the global launch of SunScript™ One Step Reverse Transcriptase (RT)-PCR Kit, the second product of its SunScript™ product line for parallel transcription and amplification of genomic information for a multitude of applications in molecular biology and diagnostics research. SunScript™ [...]

Microsaic Miniaturised Mass Spectrometry Instruments Now Compatible with the Clarity Chromatography Control Platform

Microsaic Systems plc (AIM: MSYS), the high technology company developing the next generation of miniaturised mass spectrometry (MS) instruments, is pleased to announce that its product range is now compatible with Clarity Chromatography Software, the advanced Chromatography Data Station developed by Data Apex. The Clarity software interface includes control modules for data acquisition, processing and [...]

Repligen Appoints Glenn P. Muir to Board of Directors

WALTHAM, MA –– Repligen Corporation (NASDAQ:RGEN) today announced that life sciences industry veteran Glenn P. Muir has been elected to its Board of Directors and appointed as a member of its Audit Committee. Mr. Muir brings over 30 years of experience to the director role, most recently as Chief Financial Officer and Executive Vice President, [...]

Gen9 Announces Call for Entries for the Fourth Annual G-Prize

CAMBRIDGE, Mass. —– Gen9, Inc., the pioneer in developing scalable technologies for synthesizing and assembling DNA, today announced that it is accepting entries for its fourth annual G-Prize competition. Launched and exclusively run by Gen9, the G-Prize is an annual contest designed to foster groundbreaking research in synthetic biology. The winning entrants are provided access [...]

Trajan announces landmark collaboration in R&D and manufacturing with Australian academia and government

Melbourne, Australia: Trajan Scientific and Medical (Trajan) continues to expand their technical and research capabilities, announcing a landmark agreement with academia and government in Australia today. Trajan’s latest strategic collaboration with the University of Adelaide, supported by the South Australian Government, sees the realization of a research and development and manufacturing hub based on a [...]

Clear Labs Launches To Bring Next-Gen Genomics and Transparency to the Food Industry

MENLO PARK, Calif. -- Clear Labs, the new standard for molecular food quality, launched from stealth today and announced a $6.5M Series A financing round with participation from Khosla Ventures and Felicis Ventures, among other strategic investors. Clear Labs merges clinical-grade genomic analysis and big data analytics allowing the most respected food brands to gain [...]

Desktop Genetics Ltd Raises £1.37M GBP ($2.15M USD) Funding Investment will accelerate development of DESKGEN genome editing software platform

London UK: Desktop Genetics Ltd (“DTG” or “the Company”), a UK bioinformatics company aiming to revolutionize the way genetic researchers work, announced today that it has secured an investment of £1.37M GBP ($2.15M USD) from a syndicate of VCs and angel investors, including IQ Capital Partners, London Business Angels, the London Co-Investment Fund, Dr Jonathan [...]

Xylem Inc. announces executive leadership appointments

RYE BROOK, N.Y. -- Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today announced two significant leadership appointments, which are effective October 1, 2015. Colin Sabol has been named Senior Vice President and President, Analytics and Treatment. In this role, he will lead the global [...]

Access IBO on Knowledge Center